• Mashup Score: 0

    2023 Society of Surgical Oncology International Conference on Surgical Cancer Care Judy C. Boughey, MD, of the Mayo Clinic, discusses the decrease, over the past decade, of axillary lymph node dissection, especially in patients with node-positive breast cancer at diagnosis who had sentinel lymph node surgery after neoadjuvant chemotherapy. These findings are based on the…

    Tweet Tweets with this article
    • Judy C. Boughey, MD, on Changes in Axillary Surgical Management: An I-SPY2 Analysis https://t.co/f5EL2ibqBd #SSO2023 @DrJudyBoughey @MayoClinic @SocSurgOnc #oncology #bcsm #breastcancer

  • Mashup Score: 3

    Neoadjuvant pembrolizumab may significantly improve the management of desmoplastic melanoma, increasing the likelihood of successful resection and reducing the need for further surgery or radiation therapy, according to the response data presented at the 2022 ASCO Annual Meeting, with the surgical considerations presented at the 2023 Society of Surgical Oncology (SSO) International Conference on…

    Tweet Tweets with this article
    • During an #SSO2023 press briefing, Vernon K. Sondak, MD (@VernSondakMD) of @MoffittNews presented research from @SWOG on neoadjuvant pembrolizumab in desmoplastic #melanoma. Read more in this @ASCOPost story: https://t.co/QJaBY8051T https://t.co/FrG4DEDiZJ

  • Mashup Score: 1

    Circulating tumor DNA (ctDNA) may transform disease monitoring and guide treatment for soft-tissue sarcomas, according to data presented at the 2023 Society of Surgical Oncology (SSO) International Conference on Surgical Cancer Care.1 Findings of a retrospective review showed that 85% of patients with documented disease progression or recurrence had ctDNA levels rise accordingly, and all patients…

    Tweet Tweets with this article
    • Using Circulating Tumor DNA to Predict Early Recurrence of Soft-Tissue Sarcomas https://t.co/cx6hK4ZDL4 #SSO2023 @SocSurgOnc #sarcoma #oncology #ctDNA

  • Mashup Score: 0

    By Chase Doyle Posted: 4/6/2023 11:00:00 AM Last Updated: 4/6/2023 12:00:36 PM Neoadjuvant pembrolizumab may significantly improve the management of desmoplastic melanoma, increasing the likelihood of successful resection and reducing the need for further surgery or radiation therapy, according to the…

    Tweet Tweets with this article
    • .@ASCOPost speaks to Dr. Vernon Sondak on results from Cohort A of @SWOG S1512 trial, presented at #SSO2023 @MoffittNews. Cohort B (pts w unresectable disease) to be reported at #AACR23. Neoadjuvant Pembrolizumab in Desmoplastic Melanoma - The ASCO Post https://t.co/1cjfCkd6Le

  • Mashup Score: 6
    ExpertEd - 1 year(s) ago

    ExpertEd from Society of Surgical Oncology

    Tweet Tweets with this article
    • #SSO2023 brings two more melanoma podcasts soon to be available at https://t.co/c2Q2J3a1fj @SocSurgOnc https://t.co/mWEyArTu5H

    • RT @TJH0828: #SSO2023 brings two more melanoma podcasts soon to be available at https://t.co/c2Q2J3a1fj @SocSurgOnc

  • Mashup Score: 3

    This is a narrated and edit robotic portal lymphadenectomy performed during oncologic surgery for an incidental gallbladder cancer. This video will be shared…

    Tweet Tweets with this article
    • Most recent video - robotic portal lymphadenectomy. #SSO2023 #AHPBA23 @DanielAnayaMD @SocSurgOnc @AHPBA @EAHPBA @SAGES_Updates @acsJACS @curecc @MoffittNews @AnnSurgOncol @MHepatobiliary https://t.co/Ik9dWgVBPg

  • Mashup Score: 13

    Directing the Future of Cancer Care SSO Strategic Plan SSO is excited to introduce the new 2023 – 2027 Strategic Plan. This plan is a culmination hundreds of hours of time contributed by 215 SSO members from around the globe. These dedicated individuals served the Society in a variety of ways including task force and … Introducing SSO’s New Strategic Plan Read More »

    Tweet Tweets with this article
    • "Strengthening organizations strengthens society," said SSO President Sandra L. Wong, MD today in her SSO Presidential Address. Dr. Wong shared the 2023-27 Strategic Plan with #SSO2023 attendees this morning: https://t.co/V5vfzhNdva @dartmouth @DHMCandClinics https://t.co/fmDqjT5WDq